v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance, Shares at Dec. 31, 2024   68,629,738      
Beginning Balance at Dec. 31, 2024 $ 164,765 $ 7 $ 771,542 $ (92) $ (606,692)
Issuance of common stock upon financing, net of issuance costs, Shares   19,714,285      
Issuance of common stock upon financing, net of issuance costs 65,577 $ 2 65,575    
Issuance of common stock upon exercise of stock options, Shares   36,310      
Issuance of common stock upon exercise of stock options 57   57    
Issuance of common stock upon vesting of RSUs   700,488      
Stock-based compensation expense 6,833   6,833    
Other comprehensive income (loss) 92     92  
Net loss (35,907)       (35,907)
Ending Balance, Shares at Mar. 31, 2025   89,080,821      
Ending Balance at Mar. 31, 2025 201,417 $ 9 844,007   (642,599)
Beginning Balance, Shares at Dec. 31, 2024   68,629,738      
Beginning Balance at Dec. 31, 2024 164,765 $ 7 771,542 (92) (606,692)
Net loss (77,350)        
Ending Balance, Shares at Jun. 30, 2025   89,156,350      
Ending Balance at Jun. 30, 2025 167,877 $ 9 851,359 551 (684,042)
Beginning Balance, Shares at Mar. 31, 2025   89,080,821      
Beginning Balance at Mar. 31, 2025 $ 201,417 $ 9 $ 844,007   (642,599)
Issuance of common stock upon exercise of stock options, Shares 2 855 2    
Issuance of common stock upon vesting of RSUs   74,674      
Stock-based compensation expense $ 7,350   $ 7,350    
Other comprehensive income (loss) 551     551  
Net loss (41,443)       (41,443)
Ending Balance, Shares at Jun. 30, 2025   89,156,350      
Ending Balance at Jun. 30, 2025 $ 167,877 $ 9 851,359 551 (684,042)
Beginning Balance, Shares at Dec. 31, 2025 109,884,502 109,884,502      
Beginning Balance at Dec. 31, 2025 $ 305,259 $ 11 1,056,271 404 (751,427)
Issuance of common stock upon exercise of stock options, Shares   465,661      
Issuance of common stock upon exercise of stock options 3,230   3,230    
Issuance of common stock upon vesting of RSUs   676,314      
Stock-based compensation expense 6,120   6,120    
Other comprehensive income (loss) (164)     (164)  
Net loss (41,284)       (41,284)
Ending Balance, Shares at Mar. 31, 2026   111,026,477      
Ending Balance at Mar. 31, 2026 $ 273,161 $ 11 1,065,621 240 (792,711)
Beginning Balance, Shares at Dec. 31, 2025 109,884,502 109,884,502      
Beginning Balance at Dec. 31, 2025 $ 305,259 $ 11 1,056,271 404 (751,427)
Issuance of common stock upon exercise of stock options, Shares 721,933        
Net loss $ (84,707)        
Ending Balance, Shares at Jun. 30, 2026 111,368,283 111,368,283      
Ending Balance at Jun. 30, 2026 $ 239,167 $ 11 1,075,271 19 (836,134)
Beginning Balance, Shares at Mar. 31, 2026   111,026,477      
Beginning Balance at Mar. 31, 2026 $ 273,161 $ 11 $ 1,065,621 240 (792,711)
Issuance of common stock upon exercise of stock options, Shares 1,332 256,272 1,332    
Issuance of common stock upon vesting of RSUs   85,534      
Stock-based compensation expense $ 8,318   $ 8,318    
Other comprehensive income (loss) (221)     (221)  
Net loss $ (43,423)       (43,423)
Ending Balance, Shares at Jun. 30, 2026 111,368,283 111,368,283      
Ending Balance at Jun. 30, 2026 $ 239,167 $ 11 $ 1,075,271 $ 19 $ (836,134)